In one of the most high-profile cases of the term, the court voted 6-3 along ideological lines to uphold a state law that prohibits adolescents from using hormones and puberty blockers for gender transition.
Ongoing negotiations in Washington, D.C., could undermine or fundamentally alter the third iteration of the Healthy Indiana Plan, otherwise known as HIP.
UnitedHealthcare, Indianapolis-based Elevance Health, CVS Health’s Aetna, Cigna and more than 40 other insurers say they plan to reduce the scope of health care claims subject to prior authorization.
The Indiana Legislative Council on Wednesday approved the nearly two dozen topics that lawmakers will examine in interim study committees through the end of October.
Indiana’s wealthiest families will get funding for their children’s private-school tuition while our less-fortunate families struggle to afford preschool.
The medications still amount to around $500 per month for those without insurance—out of reach for many patients. And even for people with insurance, coverage remains uneven.
The Indianapolis-based pharmaceutical giant released its second-quarter earnings Thursday along with data from the latest studies of its weight-loss pill, orforglipron.
Over the course of a decade, Indiana’s per-enrollee costs for certain Medicaid recipients are expected to surge by 43% and 72% for lower-income and elderly Hoosiers, respectively.
